Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TGTX
TGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TGTX News
TG Therapeutics CEO to Attend Healthcare Conference
2d ago
Newsfilter
TG Therapeutics Reports Positive Phase 3 Results for BRIUMVI in MS Treatment
3d ago
NASDAQ.COM
TG Therapeutics ENHANCE Trial Achieves Primary Endpoint
3d ago
seekingalpha
TG Therapeutics Reports Positive Phase 3 ENHANCE Trial Results for BRIUMVI
3d ago
Newsfilter
TG Therapeutics Announces BRIUMVI Data Presentation Schedule at CMSC 2026
4d ago
Newsfilter
ACT Capital Management Acquires New Position in Alumis Worth $4.36 Million
May 10 2026
Yahoo Finance
S&P 500 and Nasdaq Reach New Highs on Iran Deal Hopes
May 07 2026
Yahoo Finance
TGTX Q1 2025 Earnings Call Transcript
May 06 2026
NASDAQ.COM
TG Therapeutics (TGTX) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
TG Therapeutics Q1 2026 Earnings Call Highlights
May 06 2026
seekingalpha
TG Therapeutics Raises 2026 Revenue Outlook to $925 Million
May 06 2026
stocktwits
TG Therapeutics Q1 Earnings Beat Expectations with Strong Revenue Growth
May 06 2026
seekingalpha
TG Therapeutics Set to Announce Q1 Earnings with Strong Revenue Growth
May 05 2026
seekingalpha
TG Therapeutics to Host Q1 2026 Earnings Call on May 6
Apr 30 2026
Newsfilter
TG Therapeutics Presents New Data on BRIUMVI at AAN 2026
Apr 22 2026
Newsfilter
TG Therapeutics Completes Enrollment in Phase 3 Trial for BRIUMVI
Apr 16 2026
NASDAQ.COM
Show More News
